Microbiome Therapeutics

MicroBiome Therapeutics, LLC, a biotechnology company, develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight. MicroBiome Therapeutics, LLC was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.
Company Growth (employees)
Type
Private
HQ
New Orleans, US
Founded
2009
Size (employees)
5 (est)
Website
mbiome.com
Microbiome Therapeutics was founded in 2009 and is headquartered in New Orleans, US

Key People at Microbiome Therapeutics

Mark Heiman

Mark Heiman

CSO

Microbiome Therapeutics Office Locations

Microbiome Therapeutics has an office in New Orleans
New Orleans, US (HQ)
1316 Jefferson Ave

Microbiome Therapeutics Data and Metrics

Summary Metrics

Founding Date

2009

Total Funding

$1.3 m

Latest funding size

$743.5 k

Time since last funding

almost 2 years

Investors

Microbiome Therapeutics's latest funding round in June 2015 was reported to be $743.5 k. In total, Microbiome Therapeutics has raised $1.3 m

Microbiome Therapeutics Company Life and Culture

You may also be interested in